1. Ferlay JBF, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No.5, Version 2.0. Lyon: IARC Press; 2004.
2. Tracey E, Baker D, Bishop J, et al. Cancer in New South Wales: incidence, mortality and prevalence report 2005. Sydney: Cancer Institute NSW; 2007.
3. Pisters KMW, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol. 2005;23:3270–8.
4. Gandara DR, Chansky K, Albain KS, et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer. Phase II Southwest Oncology Group Study S9504. J Clin Oncol. 2003;21:2004–10.
5. Bedano PM, Neubauer M, Ansari R, et al. Phase III study of cisplatin plus etoposide with concurrent chest radiation followed by docetaxel vs. observation in patients with stage III non-small cell lung cancer: an interim toxicity analysis of consolidation therapy. J Clin Oncol. 2006;24:374s (suppl; abstr 7043).